JACOBS LEVY EQUITY MANAGEMENT, INC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in REGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$165,468,582

-$39,070,021 QoQ

Shares Held

214,160

-19.2% QoQ

Ownership

0.204%

of shares outstanding

% of Portfolio

0.74%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 72.56210310048561.ToString("F0")% Shared 0.ToString("F0")% None 27.43789689951438.ToString("F0")%

Healthcare · as of Mar 31, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $705,368,973 across 85 Biotechnology names. REGN ranks #1 (23.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	214,160	$165,468,582
2	INCY	Incyte Corp	1,717,978	$161,696,089
3	ALNY	Alnylam Pharmaceuticals, Inc.	212,204	$70,211,937
4	HALO	Halozyme Therapeutics, Inc.	789,429	$51,020,796
5	RARE	Ultragenyx Pharmaceutical Inc.	1,431,071	$29,980,937
6	EXEL	Exelixis, Inc.	425,982	$18,270,367
7	AUPH	Aurinia Pharmaceuticals Inc.	1,097,189	$16,260,340
8	ARVN	Arvinas, Inc.	1,441,521	$15,280,122

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$165,468,582	214,160	-19.2%	Shares	Sole	2026-05-15
2025-12-31	$204,538,603	264,991	-8.0%	Shares	Sole	2026-02-13
2025-09-30	$161,866,849	287,881	+22.9%	Shares	Sole	2025-11-17
2025-06-30	$122,990,175	234,267	+31261.0%	Shares	Sole	2025-08-14
2025-03-31	$473,769	747	-11.8%	Shares	Sole	2025-05-15
2024-12-31	$603,343	847	-96.4%	Shares	Sole	2025-02-14
2024-09-30	$24,799,802	23,591	+76.3%	Shares	Sole	2024-11-14
2024-06-30	$14,060,679	13,378	+3595.6%	Shares	Sole	2024-08-14
2024-03-31	$348,421	362	+1.7%	Shares	Sole	2024-05-15
2023-12-31	$312,671	356	+1.7%	Shares	Sole	2024-02-14
2021-12-31	$221,032	350	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.